Top

Gepubliceerd in:

20-06-2016 | Review

The health-related quality of life of ankylosing spondylitis patients assessed by SF-36: a systematic review and meta-analysis

Auteurs: Xiao Yang, Dazhi Fan, Qing Xia, Mengmeng Wang, Xu Zhang, Xiaona Li, Guoqi Cai, Li Wang, Lihong Xin, Shengqian Xu, Faming Pan

Gepubliceerd in: Quality of Life Research | Uitgave 11/2016

Abstract

Purpose

The main purpose of this meta-analysis was to evaluate the impact of ankylosing spondylitis on the health-related quality of life assessed by the Medical Outcomes Short-Form-36 questionnaire (SF-36).

Methods

A systematic literature search was performed on PubMed and Web of Science until January 22, 2016 to obtain eligible studies. Random effect model was performed to summarize the scores of each domain. The radar chart was used to compare the scores of AS patients with other health conditions. Spearman’s correlation analysis and meta-regression were used to explore the related factors. STATA (version 11.0) and SPSS (version 13.0) were adopted in this meta-analysis.

Results

Thirty-eight studies were included in this study, which were all reliable to summarize the scores of the SF-36. Pooled mean scores of the physical health domains ranged from 45.93 to 58.17, with the RP and PF domains being the lowest and the highest, respectively. Pooled mean scores of the mental health domains ranged from 47.49 to 62.52, with the VT and SF domains being the lowest and the highest, respectively. Besides, the physical component summary was lower than the mental component summary. BASDAI and BASFI were negatively associated with some domains of the SF-36 significantly. Patients with AS had a substantial impaired HRQoL in comparison with the general population.

Conclusions

AS could adversely affect the HRQoL of patients. Measuring HRQoL should be considered as an essential part of the overall assessment of health status of AS patients, which would provide valuable clues for improving the management of disease and making decisions regarding treatment.

vorige artikel EQ-5D in Central and Eastern Europe: 2000–2015

volgende artikel Interventions that improve health-related quality of life in patients with myocardial infarction

Alleen toegankelijk voor geautoriseerde gebruikers

Braun, J., & Sieper, J. (2007). Ankylosing spondylitis. Lancet, 369(9570), 1379–1390. doi:10.1016/S0140-6736(07)60635-7.PubMedCrossRef

Gran, J. T., & Husby, G. (1993). The epidemiology of ankylosing spondylitis. Seminars in Arthritis and Rheumatism, 22(5), 319–334.PubMedCrossRef

Exarchou, S., Lie, E., Lindstrom, U., Askling, J., Forsblad-d’Elia, H., Turesson, C., et al. (2015). Mortality in ankylosing spondylitis: results from a nationwide population-based study. Annals of the Rheumatic Diseases,. doi:10.1136/annrheumdis-2015-207688.PubMed

Feldtkeller, E., Khan, M. A., van der Heijde, D., van der Linden, S., & Braun, J. (2003). Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatology International, 23(2), 61–66.PubMed

Ward, M. M., Weisman, M. H., Davis, J. C, Jr., & Reveille, J. D. (2005). Risk factors for functional limitations in patients with long-standing ankylosing spondylitis. Arthritis and Rheumatism, 53(5), 710–717. doi:10.1002/art.21444.PubMedPubMedCentralCrossRef

Missaoui, B., & Revel, M. (2006). Fatigue in ankylosing spondylitis. Annales de réadaptation et de médecine physique, 49(6), 305–308, 389–391. doi:10.1016/j.annrmp.2006.03.007.

Haywood, K. L., Packham, J. C., & Jordan, K. P. (2014). Assessing fatigue in ankylosing spondylitis: the importance of frequency and severity. Rheumatology (Oxford), 53(3), 552–556. doi:10.1093/rheumatology/ket397.CrossRef

Bedaiwi, M., Sari, I., Thavaneswaran, A., Ayearst, R., Haroon, N., & Inman, R. D. (2015). Fatigue in ankylosing spondylitis and nonradiographic axial spondyloarthritis: Analysis from a longitudinal observation cohort. Journal of Rheumatology, 42(12), 2354–2360. doi:10.3899/jrheum.150463.PubMedCrossRef

van Tubergen, A., Coenen, J., Landewe, R., Spoorenberg, A., Chorus, A., Boonen, A., et al. (2002). Assessment of fatigue in patients with ankylosing spondylitis: A psychometric analysis. Arthritis and Rheumatism, 47(1), 8–16.PubMedCrossRef

10.

Hakkou, J., Rostom, S., Mengat, M., Aissaoui, N., Bahiri, R., & Hajjaj-Hassouni, N. (2013). Sleep disturbance in Moroccan patients with ankylosing spondylitis: Prevalence and relationships with disease-specific variables, psychological status and quality of life. Rheumatology International, 33(2), 285–290. doi:10.1007/s00296-012-2376-6.PubMedCrossRef

11.

Boonen, A., Chorus, A., Miedema, H., van der Heijde, D., Landewe, R., Schouten, H., et al. (2001). Withdrawal from labour force due to work disability in patients with ankylosing spondylitis. Annals of the Rheumatic Diseases, 60(11), 1033–1039.PubMedPubMedCentralCrossRef

12.

Barlow, J. H., Wright, C. C., Williams, B., & Keat, A. (2001). Work disability among people with ankylosing spondylitis. Arthritis and Rheumatism, 45(5), 424–429.PubMedCrossRef

13.

Dincer, U., Cakar, E., Kiralp, M. Z., & Dursun, H. (2007). Assessment of sexual dysfunction in male patients with ankylosing spondylitis. Rheumatology International, 27(6), 561–566. doi:10.1007/s00296-006-0248-7.PubMedCrossRef

14.

Oh, J. S., Heo, H. M., Kim, Y. G., Lee, S. G., Lee, C. K., & Yoo, B. (2009). The effect of anti-tumor necrosis factor agents on sexual dysfunction in male patients with ankylosing spondylitis: A pilot study. International Journal of Impotence Research, 21(6), 372–375. doi:10.1038/ijir.2009.44.PubMedCrossRef

15.

Cella, D., & Nowinski, C. J. (2002). Measuring quality of life in chronic illness: The functional assessment of chronic illness therapy measurement system. Archives of Physical Medicine and Rehabilitation, 83(12 Suppl 2), S10–S17. doi:10.1053/apmr.2002.36959.PubMedCrossRef

16.

Ware, J., & Sherbourne, S. D. (1992). The MOS 36-item short form health survey (SF-36). 1. Conceptual frame-work and item selection. Medical Care, 30, 473–481.PubMedCrossRef

17.

Ware, J. E, Jr. (2000). Using generic measures of functional health and well-being to increase understanding of disease burden. Spine, 25(12), 1467.PubMedCrossRef

18.

Ozgul, A., Peker, F., Taskaynatan, M. A., Tan, A. K., Dincer, K., & Kalyon, T. A. (2006). Effect of ankylosing spondylitis on health-related quality of life and different aspects of social life in young patients. Clinical Rheumatology, 25(2), 168–174. doi:10.1007/s10067-005-1150-5.PubMedCrossRef

19.

Husted, J. A., Gladman, D. D., Farewell, V. T., Long, J. A., & Cook, R. J. (1997). Validating the SF-36 health survey questionnaire in patients with psoriatic arthritis. Journal of Rheumatology, 24(3), 511–517.PubMed

20.

Dougados, M., & Baeten, D. (2011). Spondyloarthritis. Lancet, 377(9783), 2127–2137. doi:10.1016/S0140-6736(11)60071-8.PubMedCrossRef

21.

von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gotzsche, P. C., Vandenbroucke, J. P., et al. (2007). The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. Preventive Medicine, 45(4), 247–251.CrossRef

22.

Vandenbroucke, J. P., von Elm, E., Altman, D. G., Gotzsche, P. C., Mulrow, C. D., Pocock, S. J., et al. (2014). Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration. International Journal of Surgery, 12(12), 1500–1524. doi:10.1016/j.ijsu.2014.07.014.PubMedCrossRef

23.

Matcham, F., Scott, I. C., Rayner, L., Hotopf, M., Kingsley, G. H., Norton, S., et al. (2014). The impact of rheumatoid arthritis on quality-of-life assessed using the SF-36: A systematic review and meta-analysis. Seminars in Arthritis and Rheumatism, 44(2), 123–130. doi:10.1016/j.semarthrit.2014.05.001.PubMedCrossRef

24.

Zhang, S.-K., Guo, L.-W., Chen, Q., Zhang, M., Liu, S.-Z., Quan, P.-L., et al. (2015). Prevalence of human papillomavirus 16 in esophageal cancer among the Chinese population: A systematic review and meta-analysis. Asian Pacific Journal of Cancer Prevention, 15(23), 10143–10149. doi:10.7314/apjcp.2014.15.23.10143.CrossRef

25.

Yang, B., Fan, S., Zhi, X., Wang, Y., Wang, Y., Zheng, Q., et al. (2015). Prevalence of hyperhomocysteinemia in China: A systematic review and meta-analysis. Nutrients, 7(1), 74–90. doi:10.3390/nu7010074.CrossRef

26.

Higgins, J. P., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003). Measuring inconsistency in meta-analyses. BMJ, 327(7414), 557–560. doi:10.1136/bmj.327.7414.557.PubMedPubMedCentralCrossRef

27.

Harris, R., Bradburn, M., Deeks, J., Harbord, R., Altman, D., & Steichen, T. (2010). Stata module for fixed and random effects meta-analysis. Statistical software components. Department of Economics, Boston College, USA.

28.

Ribu, L., Hanestad, B. R., Moum, T., Birkeland, K., & Rustoen, T. (2007). A comparison of the health-related quality of life in patients with diabetic foot ulcers, with a diabetes group and a nondiabetes group from the general population. Quality of Life Research, 16(2), 179–189. doi:10.1007/s11136-006-0031-y.PubMedCrossRef

29.

Jenkinson, C., Coulter, A., & Wright, L. (1993). Short-form 36 (SF-36) health survey questionnaire: Normative data for adults of working age. British Medical Journal, 29, 1437–1440.CrossRef

30.

Clarke, P. M., Simon, J., Cull, C. A., & Holman, R. R. (2006). Assessing the impact of visual acuity on quality of life in individuals with type 2 diabetes using the short form-36. Diabetes Care, 29(7), 1506–1511. doi:10.2337/dc05-2150.PubMedCrossRef

31.

Ward, M. M. (1999). Health-related quality of life in ankylosing spondylitis: A survey of 175 patients. Arthritis Care & Research, 12(4), 247–255.CrossRef

32.

Tubergen, A. V., Coenen, J., Landewe, R., Spoorenberg, A., Chorus, A., Boonen, A., et al. (2002). Assessment of fatigue in patients with ankylosing spondylitis: A psychometric analysis. Arthritis and Rheumatism, 47(1), 8–16.PubMedCrossRef

33.

Ariza-Ariza, R., Hernandez-Cruz, B., & Navarro-Sarabia, F. (2003). Physical function and health-related quality of life of Spanish patients with ankylosing spondylitis. Arthritis and Rheumatism, 49(4), 483–487. doi:10.1002/art.11197.PubMedCrossRef

34.

Chorus, A. M., Miedema, H. S., Boonen, A., & Van Der Linden, S. (2003). Quality of life and work in patients with rheumatoid arthritis and ankylosing spondylitis of working age. Annals of the Rheumatic Diseases, 62(12), 1178–1184.PubMedPubMedCentralCrossRef

35.

van Tubergen, A., Landewe, R., Heuft-Dorenbosch, L., Spoorenberg, A., van der Heijde, D., van der Tempel, H., et al. (2003). Assessment of disability with the World Health Organisation Disability Assessment Schedule II in patients with ankylosing spondylitis. Annals of the Rheumatic Diseases, 62(2), 140–145.PubMedPubMedCentralCrossRef

36.

Dagfinrud, H., Mengshoel, A. M., Hagen, K. B., Loge, J. H., & Kvien, T. K. (2004). Health status of patients with ankylosing spondylitis: A comparison with the general population. Annals of the Rheumatic Diseases, 63(12), 1605–1610. doi:10.1136/ard.2003.019224.PubMedPubMedCentralCrossRef

37.

Barkham, N., Kong, K. O., Tennant, A., Fraser, A., Hensor, E., Keenan, A. M., et al. (2005). The unmet need for anti-tumour necrosis factor (anti-TNF) therapy in ankylosing spondylitis. Rheumatology (Oxford), 44(10), 1277–1281. doi:10.1093/rheumatology/keh713.CrossRef

38.

Braun, J., Brandt, J., Listing, J., Zink, A., Alten, R., Burmester, G., et al. (2005). Two year maintenance of efficacy and safety of infliximab in the treatment of ankylosing spondylitis. Annals of the Rheumatic Diseases, 64(2), 229–234. doi:10.1136/ard.2004.025130.PubMedCrossRef

39.

Heiberg, M. S., Nordvag, B. Y., Mikkelsen, K., Rodevand, E., Kaufmann, C., Mowinckel, P., et al. (2005). The comparative effectiveness of tumor necrosis factor-blocking agents in patients with rheumatoid arthritis and patients with ankylosing spondylitis: A six-month, longitudinal, observational, multicenter study. Arthritis and Rheumatism, 52(8), 2506–2512. doi:10.1002/art.21209.PubMedCrossRef

40.

41.

Cakar, E., Dincer, U., Kiralp, M., Taskaynatan, M., Yasar, E., Bayman, E., et al. (2007). Sexual problems in male ankylosing spondylitis patients: relationship with functionality, disease activity, quality of life, and emotional status. Clinical Rheumatology, 26(10), 1607–1613.PubMedCrossRef

42.

Boonen, A., Patel, V., Traina, S., Chiou, C. F., Maetzel, A., & Tsuji, W. (2008). Rapid and sustained improvement in health-related quality of life and utility for 72 weeks in patients with ankylosing spondylitis receiving etanercept. Journal of Rheumatology, 35(4), 662–667.PubMed

43.

Choi, C. B., Kim, T. J., Park, H. J., Uhm, W. S., Jun, J. B., Bae, S. C., et al. (2008). Safety and clinical responses in ankylosing spondylitis after three months of etanercept therapy. Journal of Korean Medical Science, 23(5), 852–856. doi:10.3346/jkms.2008.23.5.852.PubMedPubMedCentralCrossRef

44.

Maksymowych, W., Mallon, C., Morrow, S., Shojania, K., Olszynski, W., Wong, R., et al. (2009). Development and validation of the spondyloarthritis research consortium of Canada (SPARCC) enthesitis index. Annals of the Rheumatic Diseases, 68(6), 948–953.PubMedCrossRef

45.

Mustur, D., Vesovic-Potic, V., Stanisavljevic, D., Ille, T., & Ille, M. (2009). Assessment of functional disability and quality of life in patients with ankylosing spondylitis. Srpski Arhiv za Celokupno Lekarstvo, 137(9–10), 524–528.PubMedCrossRef

46.

Salaffi, F., Carotti, M., Gasparini, S., Intorcia, M., & Grassi, W. (2009). The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: A comparison with a selected sample of healthy people. Health and Quality Life Outcomes, 7, 25. doi:10.1186/1477-7525-7-25.CrossRef

47.

Deodhar, A., Braun, J., Inman, R. D., Mack, M., Parasuraman, S., Buchanan, J., et al. (2010). Golimumab reduces sleep disturbance in patients with active ankylosing spondylitis: Results from a randomized, placebo-controlled trial. Arthritis Care & Research, 62(9), 1266–1271. doi:10.1002/acr.20233.CrossRef

48.

Torres, T. M., Ferraz, M. B., & Ciconelli, R. M. (2010). Resource utilisation and cost of ankylosing spondylitis in Brazil. Clinical and Experimental Rheumatology, 28(4), 490–497.PubMed

49.

Bodur, H., Ataman, S., Rezvani, A., Bugdayci, D. S., Cevik, R., Birtane, M., et al. (2011). Quality of life and related variables in patients with ankylosing spondylitis. Quality of Life Research, 20(4), 543–549. doi:10.1007/s11136-010-9771-9.PubMedCrossRef

50.

Hakkou, J., Rostom, S., Aissaoui, N., Berrada, K., Abouqal, R., Bahiri, R., et al. (2011). Psychological status in Moroccan patients with ankylosing spondylitis and its relationships with disease parameters and quality of life. Journal of Clinical Rheumatology, 17(8), 424–428.PubMedCrossRef

51.

Ovayolu, N., Ovayolu, O., & Karadag, G. (2011). Health-related quality of life in ankylosing spondylitis, fibromyalgia syndrome, and rheumatoid arthritis: a comparison with a selected sample of healthy individuals. Clinical Rheumatology, 30(5), 655–664.PubMedCrossRef

52.

Ozdemir, O. (2011). Quality of life in patients with ankylosing spondylitis: Relationships with spinal mobility, disease activity and functional status. Rheumatology International, 31(5), 605–610. doi:10.1007/s00296-009-1328-2.PubMedCrossRef

53.

Revicki, D. A., Rentz, A. M., Luo, M. P., & Wong, R. L. (2011). Psychometric characteristics of the short form 36 health survey and functional assessment of chronic illness Therapy-Fatigue subscale for patients with ankylosing spondylitis. Health and Quality Life Outcomes, 9, 36. doi:10.1186/1477-7525-9-36.CrossRef

54.

Ibn Yacoub, Y., Amine, B., Laatiris, A., & Hajjaj-Hassouni, N. (2012). Gender and disease features in Moroccan patients with ankylosing spondylitis. Clinical Rheumatology, 31(2), 293–297. doi:10.1007/s10067-011-1819-x.PubMedCrossRef

55.

Packham, J. C., Jordan, K. P., Haywood, K. L., Garratt, A. M., & Healey, E. L. (2012). Evaluation of Ankylosing Spondylitis Quality of Life questionnaire: Responsiveness of a new patient-reported outcome measure. Rheumatology, 51(4), 707–714. doi:10.1093/rheumatology/ker377.PubMedCrossRef

56.

Pimentel-Santos, F., Pinto, T., Santos, H., Barcelos, A., Cunha, I., Branco, J., et al. (2012). Portuguese version of the bath indexes for ankylosing spondylitis patients: A cross-cultural adaptation and validation. Clinical Rheumatology, 31(2), 341–346.PubMedCrossRef

57.

Akad, K., Solmaz, D., Sari, I., Onen, F., Akkoc, N., & Akar, S. (2013). Performance of response scales of activity and functional measures of ankylosing spondylitis: Numerical rating scale versus visual analog scale. Rheumatology International, 33(10), 2617–2623. doi:10.1007/s00296-013-2789-x.PubMedCrossRef

58.

Alkan, B., Fidan, F., Erten, Ş., Aksekili, H., Alemdar, A., Eroğlu, E., et al. (2013). Fatigue and correlation with disease-specific variables, spinal mobility measures, and health-related quality of life in ankylosing spondylitis. Modern Rheumatology, 23(6), 1101–1107.PubMedCrossRef

59.

Cho, H., Kim, T., Kim, T. H., Lee, S., & Lee, K. H. (2013). Spinal mobility, vertebral squaring, pulmonary function, pain, fatigue, and quality of life in patients with ankylosing spondylitis. Annals of Rehabilitation Medicine, 37(5), 675–682. doi:10.5535/arm.2013.37.5.675.PubMedPubMedCentralCrossRef

60.

Yigit, S., Sahin, Z., Demir, S., & Aytac, D. (2013). Home-based exercise therapy in ankylosing spondylitis: short-term prospective study in patients receiving tumor necrosis factor alpha inhibitors. Rheumatology International, 33(1), 71–77.PubMedCrossRef

61.

Yılmaz, O., Tutoğlu, A., Garip, Y., Ozcan, E., & Bodur, H. (2013). Health-related quality of life in Turkish patients with ankylosing spondylitis: impact of peripheral involvement on quality of life in terms of disease activity, functional status, severity of pain, and social and emotional functioning. Rheumatology International, 33(5), 1159–1163.PubMedCrossRef

62.

Bao, C., Huang, F., Khan, M. A., Fei, K., Wu, Z., Han, C., et al. (2014). Safety and efficacy of golimumab in Chinese patients with active ankylosing spondylitis: 1-year results of a multicentre, randomized, double-blind, placebo-controlled phase III trial. Rheumatology (Oxford), 53(9), 1654–1663. doi:10.1093/rheumatology/keu132.CrossRef

63.

Dundar, U., Solak, O., Toktas, H., Demirdal, U. S., Subasi, V., Kavuncu, V., et al. (2014). Effect of aquatic exercise on ankylosing spondylitis: A randomized controlled trial. Rheumatology International, 34(11), 1505–1511. doi:10.1007/s00296-014-2980-8.PubMedCrossRef

64.

Osterhaus, J. T., & Purcaru, O. (2014). Discriminant validity, responsiveness and reliability of the arthritis-specific Work Productivity Survey assessing workplace and household productivity within and outside the home in patients with axial spondyloarthritis, including nonradiographic axial spondyloarthritis and ankylosing spondylitis. Arthritis Research & Therapy, 16(4), R164. doi:10.1186/Ar4680.CrossRef

65.

Webers, C., Essers, I., Ramiro, S., Stolwijk, C., Landewe, R., van der Heijde, D., et al. (2014). Gender-attributable differences in outcome of ankylosing spondylitis: Long-Term Results from the Outcome in Ankylosing Spondylitis International Study. Arthritis & Rheumatology, 66, S1137.

66.

Erkol, İ. E., Demirci, K., Doğru, A., & Şahin, M. (2015). Ankylosing spondylitis patients with Type D personality have worse clinical status. Modern Rheumatology, 29, 1–8.

67.

Jennings, F., Oliveira, H. A., de Souza, M. C., Cruz Vda, G., & Natour, J. (2015). Effects of aerobic training in patients with ankylosing spondylitis. Journal of Rheumatology, 42(12), 2347–2353. doi:10.3899/jrheum.150518.PubMedCrossRef

68.

Pelaez-Ballestas, I., Boonen, A., Vazquez-Mellado, J., Reyes-Lagunes, I., Hernandez-Garduno, A., Goycochea, M. V., et al. (2015). Coping strategies for health and daily-life stressors in patients with rheumatoid arthritis, ankylosing spondylitis, and gout: STROBE-compliant article. Medicine (Baltimore), 94(10), e600. doi:10.1097/MD.0000000000000600.CrossRef

69.

Smith, B. H., Elliott, A. M., Chambers, W. A., Smith, W. C., Hannaford, P. C., & Penny, K. (2001). The impact of chronic pain in the community. Family Practice, 18(3), 292–299.PubMedCrossRef

70.

Carmona, L., Ballina, J., Gabriel, R., Laffon, A., & EPISER Study Group. (2001). The burden of musculoskeletal diseases in the general population of Spain: Results from a national survey. Annals of the Rheumatic Diseases, 60(11), 1040–1045.PubMedPubMedCentralCrossRef

71.

Ware, J. E, Jr. (2000). SF-36 health survey update. Spine, 25(24), 3130–3139.PubMedCrossRef

72.

Barlow, J. H., Macey, S. J., & Struthers, G. R. (1993). Gender, depression, and ankylosing spondylitis. Arthritis Care & Research, 6(1), 45–51.CrossRef

73.

Matcham, F., Rayner, L., Steer, S., & Hotopf, M. (2013). The prevalence of depression in rheumatoid arthritis: A systematic review and meta-analysis. Rheumatology (Oxford), 52(12), 2136–2148. doi:10.1093/rheumatology/ket169.CrossRef

74.

Petitti, D. B. (2001). Approaches to heterogeneity in meta-analysis. Statistics in Medicine, 20(23), 3625–3633.PubMedCrossRef

75.

Robert, S., Cherepanov, D., Palta, M., Dunham, N., Feeny, D., & Fryback, D. (2009). Socioeconomic status and age variations in health-related quality of life: results from the National Health Measurement Study. Journal of Gerontology, 64B, 378–389.CrossRef

76.

De Vogli, R., Gimeno, D., & Kivimaki, M. (2008). Socioeconomic inequalities in health in 22 European countries. New England Journal of Medicine, 359(12), 1290. doi:10.1056/NEJMc081414. author reply 1290–1291.PubMedCrossRef

77.

Kidd, B., Mullee, M., Frank, A., & Cawley, M. (1988). Disease expression of ankylosing spondylitis in males and females. The Journal of Rheumatology, 15(9), 1407–1409.PubMed

78.

Gran, J. T., & Husby, G. (1990). Ankylosing spondylitis in women. Seminars in Arthritis and Rheumatism, 19(5), 303–312.PubMedCrossRef

79.

Jimenez-Balderas, F. J., & Mintz, G. (1993). Ankylosing spondylitis: Clinical course in women and men. The Journal of Rheumatology, 20(12), 2069–2072.PubMed

80.

Blazer, D., Burchett, B., Service, C., & George, L. K. (1991). The association of age and depression among the elderly: An epidemiologic exploration. Journal of Gerontology, 46(6), M210–M215.PubMedCrossRef

81.

Stordal, E., Mykletun, A., & Dahl, A. A. (2003). The association between age and depression in the general population: A multivariate examination. Acta Psychiatrica Scandinavica, 107(2), 132–141.PubMedCrossRef

82.

Kim, S. M., Jung, J. W., Park, I. W., Ahn, C. M., Kim, Y. I., Yoo, K. H., et al. (2016). Gender differences in relations of smoking status, depression, and suicidality in Korea: Findings from the Korea National Health and Nutrition Examination Survey 2008–2012. Psychiatry Investigation, 13(2), 239–246. doi:10.4306/pi.2016.13.2.239.PubMedPubMedCentralCrossRef

83.

Calin, A., Garrett, S., Whitelock, H., Kennedy, L. G., O’Hea, J., Mallorie, P., et al. (1994). A new approach to defining functional ability in AS: The development of the Bath ankylosing spondylitis functional index. Journal of Rheumatology, 21, 2281–2285.PubMed

84.

Garrett, S., Jenkinson, T., Kennedy, L., Whitelock, H., Gaisford, P., & Calin, A. (1994). A new approach to defining disease status in AS: The Bath ankylosing spondylitis disease activity index. Journal of Rheumatology, 21, 2286–2291.PubMed

Titel: The health-related quality of life of ankylosing spondylitis patients assessed by SF-36: a systematic review and meta-analysis
Auteurs: Xiao Yang
Dazhi Fan
Qing Xia
Mengmeng Wang
Xu Zhang
Xiaona Li
Guoqi Cai
Li Wang
Lihong Xin
Shengqian Xu
Faming Pan
Publicatiedatum: 20-06-2016
Uitgeverij: Springer International Publishing
Gepubliceerd in: Quality of Life Research / Uitgave 11/2016
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-016-1345-z

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Purpose

Methods

Results

Conclusions

Log in om toegang te krijgen

Andere artikelen Uitgave 11/2016

Measuring health-related quality of life in patients with conservatively managed stage 5 chronic kidney disease: limitations of the Medical Outcomes Study Short Form 36: SF-36

International SF-36 reference values in patients with ischemic heart disease

The development and acceptability of symptom management quality improvement reports based on patient-reported data: an overview of methods used in PROSSES

Individualized quality of life of severely affected multiple sclerosis patients: practicability and value in comparison with standard inventories

A review of empirical research related to the use of small quantitative samples in clinical outcome scale development

Phenylketonuria patients’ and their parents’ acceptance of the disease: multi-centre study